Ligand Pharmaceuticals | Eiendeler



Assets Endring Dato
Amgen USD 89.37B 2.47B 2025-03
Arrowhead Research USD 1.01B 126.11M 2024-12
Baxter International USD 25.78B 894M 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
Ligand Pharmaceuticals USD 941.77M 13.09M 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
Merck USD 115.12B 1.98B 2025-03
Pacira USD 1.55B 31.82M 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Veracyte USD 1.3B 25.01M 2024-12



Ligand Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.